-
Mashup Score: 1Vin Tangpricha, MD, PhD (@vtangpricha.bsky.social) - 1 month(s) ago
This months #EndocrinePractice #ArtificialIntelligence #AI in detecting malignant #thyroid nodules? Wow! @theaace.bsky.social Read here https://www.endocrinepractice.org/article/S1530-891X(24)00647-5/abstract
Source: bsky.appCategories: General Medicine News, EndocrinologyTweet
-
Mashup Score: 0Vin Tangpricha, MD, PhD (@vtangpricha.bsky.social) - 1 month(s) ago
This months #EndocrinePractice Safety and Efficacy of the Novel RNA Interference by @deepduttaendo and colleagues Therapies for Hypertriglyceridemia and Mixed Hyperlipidemia Management: A Systematic Review and Meta-analysis https://www.endocrinepractice.org/article/S1530-891X%2824%2900662-1/fulltext
Source: bsky.appCategories: General Medicine News, EndocrinologyTweet
-
Mashup Score: 0Vin Tangpricha, MD, PhD (@vtangpricha.bsky.social) - 1 month(s) ago
Professor @EmoryDeptofMed Eminent Physician @emoryhealthcare Endocrinologist Editor #EndocrinePractice @ATLHawks #TrueToAtlanta @Braves #BravesCountry
Source: bsky.appCategories: General Medicine News, EndocrinologyTweet
-
Mashup Score: 0Vin Tangpricha, MD, PhD (@vtangpricha.bsky.social) - 1 month(s) ago
Professor @EmoryDeptofMed Eminent Physician @emoryhealthcare Endocrinologist Editor #EndocrinePractice @ATLHawks #TrueToAtlanta @Braves #BravesCountry
Source: bsky.appCategories: General Medicine News, EndocrinologyTweet
-
Mashup Score: 3Improved Clinical Outcomes Associated With Hungry Bone Syndrome Following Parathyroidectomy in Dialysis Patients - 1 month(s) ago
Hungry bone syndrome (HBS) is a common complication after parathyroidectomy in dialysis patients with severe secondary hyperparathyroidism. The rapid decline in parathyroid hormone (PTH) levels diminishes bone resorption and accelerates bone formation. This causes a significant influx of calcium and phosphate into the bone, resulting in severe and prolonged hypocalcemia. While previous studies have established risk factors for HBS, the outcomes beyond the reduced recurrence rate of hyperparathyroidism have been largely unexplored.
Source: www.endocrinepractice.orgCategories: General Medicine News, EndocrinologyTweet
-
Mashup Score: 7Use of Natural Language Processing to Extract and Classify Papillary Thyroid Cancer Features From Surgical Pathology Reports - 1 month(s) ago
We aim to use Natural Language Processing to automate the extraction and classification of thyroid cancer risk factors from pathology reports.
Source: www.endocrinepractice.orgCategories: General Medicine News, EndocrinologyTweet
-
Mashup Score: 10
No meta-analysis has holistically analyzed and summarized the safety and therapeutic efficacy of the newer RNA interference (RNAi) therapies, olezarsen, plozasiran, and zodasiran, in managing conditions associated with hypertriglyceridemia (HTG).
Source: www.endocrinepractice.orgCategories: General Medicine News, EndocrinologyTweet
-
Mashup Score: 8
We examined the association of objective measures of cardiometabolic risk with progression to a high-risk for advanced fibrosis in patients with metabolic dysfunction-associated steatotic liver disease (MASLD) at initially low- and indeterminate-risk for advanced fibrosis.
Source: www.endocrinepractice.orgCategories: General Medicine News, EndocrinologyTweet
-
Mashup Score: 7Thyroid Function and Cognitive Decline: A Narrative Review - 2 month(s) ago
As the population of older adults in the United States continues to rise, understanding modifiable risk factors that contribute to cognitive decline and dementia becomes increasingly important. This narrative review summarizes existing literature on the association between thyroid function in the euthyroid range, hypothyroidism and hyperthyroidism, and cognitive outcomes in older adults.
Source: www.endocrinepractice.orgCategories: General Medicine News, EndocrinologyTweet
-
Mashup Score: 6Evaluating the Risk of Venous Thromboembolism in Transfeminine and Gender Diverse People: A Retrospective Analysis - 2 month(s) ago
The risk of venous thromboembolism (VTE) with feminizing gender-affirming hormone therapy is an area of concern. This analysis aimed to assess whether gender-affirming hormone therapy and other potential risk factors are associated with VTE in transfeminine and gender diverse individuals.
Source: www.endocrinepractice.orgCategories: General Medicine News, EndocrinologyTweet
Posted on BlueSky https://t.co/Kmr3WGbdzn